Vagal nerve stimulation as a treatment of epilepsy;La stimulation du nerf vague dans le traitement de l'épilepsie

Revue Neurologique

Volumn 161, Issue 1, 2005, Pages 128-132

  Biraben, A ^a   Stefani, C ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Epilepsy; Non pharmacologie treatment; Vagus nerve stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; NEUROTRANSMITTER; NORADRENALIN; PENICILLIN DERIVATIVE; STRYCHNINE; TETRAZOLE DERIVATIVE;

BRAIN REGION; CLINICAL TRIAL; ELECTROENCEPHALOGRAM; EPILEPSY; HEART ARRHYTHMIA; HUMAN; IMPLANTATION; NEUROANATOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT SELECTION; REVIEW; TREATMENT INDICATION; VAGUS NERVE STIMULATION;

EID: 13244287998     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(05)84987-2     Document Type: Short Survey

References (29)

1. BEN-MENACHEM E, HAMBERGER A, HEDNER T et al. (1995). Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res, 20: 221-227.
2. BEN-MENACHEM E, MANON-ESPAILLAT R, RISTANOVIC R et al. (1994). Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. Epilepsia, 35: 616-626.
3. BEN-MENACHEM E. (2002). Vagus nerve stimulation for the treatment of epilepsy. Lancet Neurol, 1: 477-482.
4. BEN-MENACHEM E. (2001). Vagus nerve stimulation, side effects, and long term safety. J Clin Neurophysiol, 18: 415-418.
5. BOON P, D'HAVE M, VAN WALLEGHEM P, MICHIELSEN G, VONCK K, CAEMAERT J, DE REUCK J. (2002). Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia, 43: 96-102.
6. DEGIORGIO CM, SCHACHTER SC, HANDFORTH A et al. (2000). Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia, 41: 1195-1200.
7. FILIPPI CG, HADDAD N, LI P, NARAYANAN JT, WATTS R. (2002). Cerebral activation during vagus nerve stimulation: a functional MR study. Epilepsia, 43: 1509-1514.
8. FROST M, GATES J, HELMERS SL, WHELESS JW et al. (2001). Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia, 42: 1148-1152.
9. HAMMOND EJ, UTHMAN BM, REID SA, WILDER BJ. (1992). Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects. Epilepsia, 33: 1013-1020.
10. HANDFORTH A, DEGORGIO CM, SCHACHTER SC et al. (1998). Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology, 51: 48-55.
11. HELMERS SL, GRIESSMER DA, DEAN JC et al. (2003). Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less. Neurology, 9: 160-164.
12. HENRY TR, VOTAW JR, FENNEL PB et al. (1999). Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology, 52: 1166-1173.
13. HENRY TR. (2003). Vagus nerve stimulation for epilepsy: anatomical, experimental and mechanistic investigations. In: Vagus nerve stimulation, Schachter SC and Schmidt D Eds. Martin Dunitz, London and New York, p. 1-31.
14. Koo B. (2001). EEG changes with vagus nerve stimulation. J Clin Neurophysiol, 18: 434-441.
15. LABAR D, MURPHY J, TECOME E. (1999). Vagus nerve stimulation for medication - resistant generalized epilepsy. E04 VNS Study Group. Neurology, 52: 1510-1512.
16. LOCKARD JC, CONGDON WC, DUCHARME LL. (1990). Feasibility and safety of vagal stimulation in monkey model. Epilepsia, 31(Suppl 2): S20-S26.
17. MAJOIE HJ, BERFELO MW, ALDENKAMP AP, EVERS SM, KESSELS AG, RENIER WO. (2001). Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neurophysiological effects, and cost-effectiveness. J Clin Neurophysiol, 18: 419-428.
18. MARROSU F, SERRA A, MALECI A, PULIGHEDDU M, BIGGIO G, PICA M. (2003). Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res, 55: 59-70.
19. MURPHY JV. (1999). Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group. J Pediatr, 134: 563-566.
20. MURPHY JV, PATIL A. (2003). Stimulation of the nervous system for the management of seizures: current and future developments. CNS Drugs, 17: 101-115.
21. NARTTOKU DK, TERRY WJ, HELFERT RH. (1995). Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res, 22: 53-62.
22. PENRY JK, DEAN JC. (1990). Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia, 31(Suppl 2): S40-S43.
23. SALFNSKY MC, BURCHIEL KJ. (1993). Vagus nerve stimulation has no effect on awake EEG rhythms in humans. Epilepsia, 34: 299-304.
24. SMYTH MD, TUBBS RS, BEBIN EM, GRABB PA, BLOUNT JP. (2003). Complications of chronic vagus nerve stimulation for epilepsy in children. J Neurosurg, 99: 500-503.
25. TAKAYA M, TERRY WJ, NARINOKU DK. (1996). Vagus nerve stimulation induces a sustained anticonvulsant effect. Epilepsia, 37: 1111-1116.
26. THE VAGUS NERVE STIMULATION STUDY GROUP. (1995). A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology, 45: 224-230.
27. WOODBURY DM, WOODBURY JW. (1990). Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia, 31(Suppl 2): S7-S19.
28. ZABARA J. (1985). Peripheral control of hypersynchronous discharges in epilepsy. Electroencephalogr Clin Neurophysiol, 61: 162.
29. ZABARA J. (1992). Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia, 33: 1005-1012.